← Back to Search

Intraocular Lens

Model DIU for Cataract

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Surgical Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months post-operative
Awards & highlights

Study Summary

This trial will compare the TECNIS Eyhance Toric II IOL to the TECNIS Synergy Toric II and the TECNIS Toric 1-Piece IOL to see which is better at correcting vision for those with astigmatism.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rotational Stability of IOL

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: TECNIS Synergy Toric IIExperimental Treatment1 Intervention
Model DFW
Group II: Eyhance Toric II IOLExperimental Treatment1 Intervention
Model DIU
Group III: TECNIS Toric 1-Piece IOLActive Control1 Intervention
Model ZCT

Find a Location

Who is running the clinical trial?

Johnson & Johnson Surgical Vision, Inc.Lead Sponsor
34 Previous Clinical Trials
8,021 Total Patients Enrolled
29 Trials studying Cataract
6,792 Patients Enrolled for Cataract
Johnson & Johnson Surgical Vision, Inc. Clinical TrialStudy DirectorJohnson & Johnson Surgical Vision, Inc.
7 Previous Clinical Trials
4,006 Total Patients Enrolled
6 Trials studying Cataract
3,971 Patients Enrolled for Cataract

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what locales is this research trial taking place?

"Presently, potential participants can join the clinical trial from 4 regional locations - Orange, San Antonio, and Los Angeles among other cities. It is paramount to find a site close to you in order to avoid excessive commuting requirements."

Answered by AI

How many participants have been accepted into this medical research program?

"Affirmative, according to clinicaltrials.gov this medical trial is currently enrolling participants. The initial posting was on June 30th 2022 and the most recent update took place on November 28th 2022. 375 individuals will be recruited from 4 distinct sites."

Answered by AI

Are there any vacancies in this clinical trial for individuals to participate?

"Affirmative. Information on clinicaltrials.gov demonstrates that this medical experiment, which was first published on June 30th 2022, is actively recruiting participants. Approximately 375 individuals are needed to be recruited from 4 distinct sites."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
New York
Texas
How old are they?
18 - 65
What site did they apply to?
Parkhurst NuVision
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~13 spots leftby Apr 2025